The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) has published a new report that analyzes the most relevant data on clinical trials authorized for rare pathologies and their evolution over the last five years in our country. The launch is framed in the context of the International Clinical Trials Day.

According to the data, a total of 929 clinical trials were authorized in Spain in 2024. Of these, 207 trials were aimed at rare diseases. A comparison of the number of clinical trials for rare diseases authorized in 2024 with that of 2023 shows an increase of 10% in the latter year. This increase is good news for the country, and especially for patients who are awaiting the arrival of a treatment, in many cases the first to treat their disease.

Access the complete note here.

You can download the infographic here.